Some large analyses report lower rates of myocardial infarction, stroke, and all-cause mortality with tirzepatide compared with GLP-1 receptor agonists, including semaglutide ( Methodological limitations of comparative data Several methodological limitations complicate direct comparisons between these agents
Patients who are pregnant or breastfeeding, have a history of medullary thyroid cancer or MEN-2 syndrome, severe gastroparesis, or certain pancreatic conditions may not be candidates
(1994) J.Pharmacol.Exp.Ther
Mark your first-use date on the pen so you never exceed the 28-day window
Every body reacts differently to these treatments
With a few lifestyle adjustments and the right support, you can ease this discomfort and stay on track toward your health goals